BofA lowered the firm’s price target on Blue Bird (BLBD) to $63.50 from $66 and keeps a Buy rating on the shares. Blue Bird “beat and raised for a seventh consecutive quarter as revamped operations continue to drive performance,” says the analyst, who maintains the firm’s 2024/25 revenue estimates and raise its 2025 EBITDA estimate 5% to $205M. The firm’s higher EBITDA estimate for 2025 is offset by higher net debt as the company reinvests in facilities, driving the firm’s lowered target, the analyst noted.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter